Nevro Corp. provides products for patients suffering from chronic pain in the United States and internationally. The company sells its products through its direct sales force, and a network of sales agents and independent distributors. Nevro was incorporated in 2006 and is headquartered in Redwood City, California.
Market Cap | 605.373 Million | Shares Outstanding | 36.12 Million | Avg 30-day Volume | 587.992 Thousand |
P/E Ratio | 0.0 | Dividend Yield | 0.0 | EPS | 2.3 |
Price to Revenue | 1.6428 | Debt to Equity | 0.6574 | EBITDA | -98.511 Million |
Price to Book Value | 2.4317 | Operating Margin | -25.276300000000003 | Enterprise Value | 562.199 Million |
Current Ratio | 6.546 | EPS Growth | -7.394 | Quick Ratio | 4.881 |
1 Yr BETA | 1.0808 | 52-week High/Low | 48.1 / 13.98 | Profit Margin | -24.2228 |
Operating Cash Flow Growth | -376.0757 | Free Cash Flow to Firm (FCFF) TTM | -103.428 Million | Free Cash Flow to Equity (FCFE) TTM | -83.934 Million |
Altman Z-Score | 0.8564 |
Please sign in first
none
none
none
Insider Name | Type | Last Reported Shares Held | Last Reported Date | Filings in past year |
---|---|---|---|---|
CARTER RICHARD B. CHIEF ACCOUNTING OFFICER |
|
37,453 | 2023-11-11 | 6 |
GROSSMAN D KEITH EXECUTIVE CHAIRMAN |
|
217,920 | 2023-10-24 | 8 |
RASHID KASHIF GENERAL COUNSEL |
|
92,877 | 2023-10-04 | 7 |
|
466,545 | 2023-09-30 | 7 | |
|
53,488 | 2023-09-30 | 5 | |
|
55,563 | 2023-09-30 | 5 | |
|
16,665 | 2023-09-30 | 5 | |
MACLEOD RODERICK H. CHIEF FINANCIAL OFFICER |
|
66,177 | 2023-08-28 | 6 |
SILLER GREG CHIEF COMMERCIAL OFFICER |
|
0 | 2023-06-19 | 2 |
|
26,866 | 2023-06-07 | 2 | |
PELLEGRINI NIAMH LOUISE CHIEF COMMERCIAL OFFICER |
|
85,967 | 2023-05-28 | 4 |
|
24,227 | 2023-05-25 | 1 | |
|
12,792 | 2023-05-25 | 1 | |
|
14,779 | 2023-05-25 | 1 | |
THORNAL KEVIN R PRESIDENT & CEO |
|
135,623 | 2023-04-24 | 2 |
|
8,198 | 2021-05-25 | 0 | |
GALLIGAN ANDREW H CHIEF FINANCIAL OFFICER |
|
59,179 | 2020-06-04 | 0 |
|
38,039 | 2020-05-21 | 0 | |
SCHMITZ PATRICK VICE PRESIDENT, OPERATIONS |
|
18,658 | 2020-02-28 | 0 |
ALLEAVITCH DOUG VP, QUALITY |
|
25,590 | 2019-11-25 | 0 |
CHRISTOFOROU CHRISTOFER VP, RESEARCH & DEVELOPMENT |
|
19,570 | 2019-11-01 | 0 |
CARTER MICHAEL COLLIER VICE PRESIDENT, SALES |
|
39,350 | 2019-02-20 | 0 |
ELGHANDOUR RAMI PRESIDENT & CEO |
|
122,387 | 2019-01-03 | 0 |
|
5,303 | 2018-05-21 | 0 | |
|
5,390 | 2018-05-21 | 0 | |
ALECXIH JAMES VICE PRESIDENT, SALES |
|
0 | 2017-12-12 | 0 |
ENXING MICHAEL VP OF SALES |
|
40,463 | 2017-04-04 | 0 |
WALKER ANDRE SENIOR VP,RESEARCH&DEVELOPMENT |
|
961 | 2016-06-08 | 0 |
|
No longer subject to file | 2015-12-31 | 0 | |
BAY CITY CAPITAL FUND IV, L.P. |
|
36,403 | 2015-06-08 | 0 |
|
1,725,379 | 2015-06-08 | 0 | |
SHANKAR BALAKRISHNAN VP, OPERATIONS |
|
0 | 2015-01-13 | 0 |
|
2,210,569 | 2014-11-12 | 0 | |
|
No longer subject to file | 2014-11-12 | 0 | |
|
No longer subject to file | 2014-11-12 | 0 | |
|
0 | 2014-11-05 | 0 |
Reporting Owners | Filing Date | Trans Date | Trans Code | Shares | Share Price | Acquired Disposed |
Shares Owned after | D/I | 10b5 | Perf 1d* | Perf 5d* | Perf 1m* | Max Gain | Max Gain Days | Max Loss | Max Loss Days |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2023-11-14 18:54:57 -0500 | 2023-11-11 | F | 230 | $15.04 | d | 37,453 | direct | -0.9953 | -4.5082 | 0.0 | 1 | -5.9719 | 5 | |||
2023-10-26 16:34:25 -0400 | 2023-10-24 | F | 6,012 | $15.75 | d | 217,920 | direct | -1.8006 | 11.2881 | 11.2881 | 6 | -1.8006 | 2 | |||
2023-10-06 17:14:02 -0400 | 2023-10-04 | F | 1,879 | $18.07 | d | 92,877 | direct | 7.2406 | -3.1927 | -5.4732 | 7.2406 | 2 | -19.1562 | 16 |
* -
Code | Definition |
---|---|
A | Grant, award or other acquisition pursuant to Rule 16b-3(d) |
C | Conversion of derivative security |
D | Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) |
E | Expiration of short derivative position |
F | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 |
G | Bona fide gift |
H | Expiration (or cancellation) of long derivative position with value received |
I | Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities |
J | Other acquisition or disposition |
L | Small acquisition under Rule 16a-6 |
M | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 |
O | Exercise of out-of-the-money derivative security |
P | Open market or private purchase of non-derivative or derivative security |
S | Open market or private sale of non-derivative or derivative security |
U | Disposition pursuant to a tender of shares in a change of control transaction |
W | Acquisition or disposition by will or the laws of descent and distribution |
X | Exercise of in-the-money or at-the-money derivative security |
Z | Deposit into or withdrawal from voting trust |
Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers
Security | Date/Time | Rebate Rate | Fee Rate | Shares Available |
---|---|---|---|---|
NEVRO CORP NVRO | 2023-11-30 19:15:04 UTC | 4.9119 | 0.4081 | 550000 |
NEVRO CORP NVRO | 2023-11-30 18:45:04 UTC | 4.9119 | 0.4081 | 550000 |
NEVRO CORP NVRO | 2023-11-30 18:15:04 UTC | 4.9119 | 0.4081 | 550000 |
NEVRO CORP NVRO | 2023-11-30 17:45:04 UTC | 4.9119 | 0.4081 | 550000 |
NEVRO CORP NVRO | 2023-11-30 17:15:04 UTC | 4.9119 | 0.4081 | 550000 |
NEVRO CORP NVRO | 2023-11-30 16:45:03 UTC | 4.9119 | 0.4081 | 550000 |
NEVRO CORP NVRO | 2023-11-30 16:15:04 UTC | 4.9119 | 0.4081 | 550000 |
NEVRO CORP NVRO | 2023-11-30 15:45:04 UTC | 4.9119 | 0.4081 | 550000 |
NEVRO CORP NVRO | 2023-11-30 15:15:04 UTC | 4.9119 | 0.4081 | 550000 |
NEVRO CORP NVRO | 2023-11-30 14:45:04 UTC | 4.9119 | 0.4081 | 550000 |
NEVRO CORP NVRO | 2023-11-30 14:15:04 UTC | 4.9119 | 0.4081 | 550000 |
NEVRO CORP NVRO | 2023-11-30 13:45:04 UTC | 4.9119 | 0.4081 | 550000 |
NEVRO CORP NVRO | 2023-11-30 13:15:04 UTC | 4.9119 | 0.4081 | 550000 |
NEVRO CORP NVRO | 2023-11-30 12:45:03 UTC | 4.9119 | 0.4081 | 550000 |
NEVRO CORP NVRO | 2023-11-29 22:15:05 UTC | 4.9119 | 0.4081 | 550000 |
NEVRO CORP NVRO | 2023-11-29 21:45:04 UTC | 4.9119 | 0.4081 | 550000 |
NEVRO CORP NVRO | 2023-11-29 21:15:05 UTC | 4.9119 | 0.4081 | 550000 |
NEVRO CORP NVRO | 2023-11-29 20:45:04 UTC | 4.9119 | 0.4081 | 550000 |
NEVRO CORP NVRO | 2023-11-29 20:15:03 UTC | 4.9119 | 0.4081 | 550000 |
NEVRO CORP NVRO | 2023-11-29 19:45:04 UTC | 4.9119 | 0.4081 | 550000 |
Holder | Issuer | Net Short Position | Position Date | Origin |
---|---|---|---|---|
FundVantage Trust- Gotham Hedged Plus Fund | NVRO | -82.0 shares, $-3247.2 | 2022-12-30 | N-PORT |
WASATCH FUNDS TRUST- Wasatch Long/Short Alpha Fund | NVRO | -16926.0 shares, $-325317.72 | 2023-09-30 | N-PORT |